These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15089030)

  • 1. Synthesis and biological activities of 8-arylflavones.
    Dao TT; Kim SB; Sin KS; Kim S; Kim HP; Park H
    Arch Pharm Res; 2004 Mar; 27(3):278-82. PubMed ID: 15089030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and inhibitory activity against COX-2 catalyzed prostaglandin production of chrysin derivatives.
    Dao TT; Chi YS; Kim J; Kim HP; Kim S; Park H
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1165-7. PubMed ID: 14980657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and PGE2 inhibitory activity of vinylated and allylated chrysin analogues.
    Dao TT; Oh JW; Chi YS; Kim HP; Sin KS; Park H
    Arch Pharm Res; 2003 Aug; 26(8):581-4. PubMed ID: 12967189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wogonin inhibits inducible prostaglandin E(2) production in macrophages.
    Wakabayashi I; Yasui K
    Eur J Pharmacol; 2000 Oct; 406(3):477-81. PubMed ID: 11040356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological acitivity of annulated pyrazoles as selective COX-2 inhibitors. I.
    Kim HH; Park JG; Moon TC; Chang HW; Jahng Y
    Arch Pharm Res; 1999 Aug; 22(4):372-9. PubMed ID: 10489876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atropisomeric myristinins: selective COX-2 inhibitors and antifungal agents from Myristica cinnamomea.
    Sawadjoon S; Kittakoop P; Kirtikara K; Vichai V; Tanticharoen M; Thebtaranonth Y
    J Org Chem; 2002 Aug; 67(16):5470-5. PubMed ID: 12153244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 2,3-diarylpyrazines and quinoxalines as selective COX-2 inhibitors.
    Singh SK; Saibaba V; Ravikumar V; Rudrawar SV; Daga P; Rao CS; Akhila V; Hegde P; Rao YK
    Bioorg Med Chem; 2004 Apr; 12(8):1881-93. PubMed ID: 15051057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide and its analogues as cyclooxygenase inhibitors.
    Noguchi T; Shimazawa R; Nagasawa K; Hashimoto Y
    Bioorg Med Chem Lett; 2002 Apr; 12(7):1043-6. PubMed ID: 11909713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of (E)-1,1,2-triarylethenes: novel inhibitors of the cyclooxygenase-2 (COX-2) isozyme.
    Uddin MJ; Rao PN; McDonald R; Knaus EE
    Bioorg Med Chem Lett; 2005 Jan; 15(2):439-42. PubMed ID: 15603969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,3-Diarylbenzopyran derivatives as a novel class of selective cyclooxygenase-2 inhibitors.
    Hyup YH; Kwan JK; Kang SH; Noh MS; Ha JY; Kyu JK; Min KM; Hoon CH; Chung S
    Bioorg Med Chem Lett; 2003 Feb; 13(3):413-7. PubMed ID: 12565941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and cyclooxygenase inhibitory properties of novel (+) 2-(6-methoxy-2-naphthyl)propanoic acid (naproxene) derivatives.
    Abadi AH; Laufer S; Lehmann J
    Arch Pharm (Weinheim); 2001 Mar; 334(3):104-6. PubMed ID: 11315336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amide derivatives of meclofenamic acid as selective cyclooxygenase-2 inhibitors.
    Kalgutkar AS; Rowlinson SW; Crews BC; Marnett LJ
    Bioorg Med Chem Lett; 2002 Feb; 12(4):521-4. PubMed ID: 11844663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and inhibition of PGE2 production of 6,8-disubstituted chrysin derivatives.
    Park H; Dao TT; Kim HP
    Eur J Med Chem; 2005 Sep; 40(9):943-8. PubMed ID: 15963606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and antiinflammatory activity relationships of wogonin derivatives.
    Jang J; Sin KS; Kim HP; Park H
    Arch Pharm Res; 2005 Aug; 28(8):877-84. PubMed ID: 16178410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pimarane cyclooxygenase 2 (COX-2) inhibitor and its structure-activity relationship.
    Suh YG; Kim YH; Park MH; Choi YH; Lee HK; Moon JY; Min KH; Shin DY; Jung JK; Park OH; Jeon RO; Park HS; Kang SA
    Bioorg Med Chem Lett; 2001 Feb; 11(4):559-62. PubMed ID: 11229771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel cyclooxygenase-inhibitory stilbenolignan from the seeds of Aiphanes aculeata.
    Lee D; Cuendet M; Vigo JS; Graham JG; Cabieses F; Fong HH; Pezzuto JM; Kinghorn AD
    Org Lett; 2001 Jul; 3(14):2169-71. PubMed ID: 11440571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Aryl/cycloalkyl-5-phenyloxazole derivatives as selective COX-2 inhibitors.
    Hashimoto H; Maeda K; Ozawa K; Haruta J; Wakitani K
    Bioorg Med Chem Lett; 2002 Jan; 12(1):65-8. PubMed ID: 11738574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiazole analogues of the NSAID indomethacin as selective COX-2 inhibitors.
    Woods KW; McCroskey RW; Michaelides MR; Wada CK; Hulkower KI; Bell RL
    Bioorg Med Chem Lett; 2001 May; 11(10):1325-8. PubMed ID: 11392547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sophoraflavanone G, a prenylated flavonoid from Sophora flavescens, on cyclooxygenase-2 and in vivo inflammatory response.
    Kim DW; Chi YS; Son KH; Chang HW; Kim JS; Kang SS; Kim HP
    Arch Pharm Res; 2002 Jun; 25(3):329-35. PubMed ID: 12135106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.